Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Cash from Operations (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Cash from Operations for 15 consecutive years, with 3675000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 26.51% to 3675000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 595000.0 through Dec 2025, down 188.41% year-over-year, with the annual reading at 1937000.0 for FY2025, 39.55% down from the prior year.
  • Cash from Operations for Q4 2025 was 3675000.0 at Aytu Biopharma, up from 618000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 9365000.0 in Q2 2023, with the low at 9148000.0 in Q3 2022.
  • Average Cash from Operations over 5 years is 2130842.11, with a median of 1190000.0 recorded in 2024.
  • The sharpest move saw Cash from Operations soared 2251.85% in 2024, then crashed 2441.34% in 2025.
  • Over 5 years, Cash from Operations stood at 8822000.0 in 2021, then skyrocketed by 72.21% to 2452000.0 in 2022, then skyrocketed by 94.49% to 135000.0 in 2023, then skyrocketed by 2251.85% to 2905000.0 in 2024, then rose by 26.51% to 3675000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 3675000.0, 618000.0, and 2803000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.